ACCELERATING EMERGING BIOPHARMASUCCESS

Ash�eld

ASHFIELD, THE PARTNER OF CHOICE FOR EMERGING BIOPHARMA

Emerging biopharma companies are driving the majority of the industry’s development pipeline and have a huge role to play in bringing innovative new medicines to market. However, the size of these companies is often a hurdle to getting treatments to patients and achieving business objectives efficiently.

Ashfield has the insights and experience to design tailored, integrated solutions. Our infrastructure allows us to execute efficiently and our flexibility means we plan and adapt very quickly to market response and volume trends.

“ The reason we partnered with Ashfield is because we’re small and we’re not trying to augment a sales force. We don’t have the infrastructure to start with such as incentive compensation, finances, cars, logistics, all that. We need them because they have this infrastructure built and that helps us tremendously. One of the best things about the relationship is the transparency…” VP of Sales

Specialists in go-to-market resources, all supported by state-of-the-art contact centers

• Expertise in specialty and rare disease

• Flexibility to grow and scale while mitigating risk, with a global footprint

• Unparalleled operational structure and systems to optimize performance, from recruitment, training and development, analytics and insights, to quality and compliance.

ASHFIELD COMMERCIALWe design and execute intelligent customer engagement models for emerging biopharma. Our unique approach involves:

ADAPTIVE ANALYTICSWith our agile data and analytics platform, every decision is driven by insight and designed to maximize ROI.

OPTIMIZED CHANNEL ENGAGEMENTIntelligent design to blend a range of resources and communication channels that effectively target and engage customers.

TAILORED EXECUTIONBuilding phenomenal teams and accelerating performance through genuine partnership and a culture of excellence.

Over 20 years’ experience

17 state-of-the-artcontact centers

21 country locations

Our global speciality experience includes:

AutoimmuneOncologyHepatitis C

HIVMultiple SclerosisNeurology

OUR COMMERCIAL SERVICESFOR EMERGING BIOPHARMA

COMMERCIAL JOURNEY

SCIENTIFIC ENGAGEMENT

MARKET ACCESS

ANALYTICS & INSIGHTS

ENGAGEMENT MODEL DESIGN TALENT LEARNING &

DEVELOPMENTEXECUTION &

ANALYTICS MEETINGS &

EVENTS

MSLs

Virtual MSLs

These services are delivered by our firewalled Medical Affairs business unit.

Research

Distribution and access strategy

Account team management

Forecasting and market sizing

Segmentation and targeting

Channel and frequency optimization

Field sales

Inside sales

Hybrid F2F/virtual reps

Specialty care teams

Key account managers

Commercial service reps

Pharmacy reps

Omnichannel engagement

Real-time recruitment

Vacancy management

Permanent recruitment

Onboarding

Trainingprograms

Measuring and responding to KPIs

Messaging effectiveness

ROI

Product launches and roadshows

Sales conferences and exhibitions

Virtual meetings

ASHFIELD PATIENT SOLUTIONS

Next-generation patient engagement programs for emerging biopharma, built on behavioral science, patient-centric technology and unparalleled collaboration. Our extensive experience:

ü ORPHANü ONCOLOGYü SPECIALTYü CHRONIC DISEASE

850>100

>30

97%

99%

ClinicalEducators

Programslaunched

Therapeuticareas

Self-management confidence

Overall satisfaction

2 100

Launch 13

Scalability

Strong client retention

Number of Clinical Educators per program

Programs from launch to 13 years

Our Patient Solutions Services for Emerging Biopharma

• Patient engagement programs, including health behaviour change and adherence strategies

• Patient education and training• Healthcare professional

education

Field based Clinical Educators

Contact Centers

Omnichannel 24/7 Support

OMNICHANNEL COMMUNICATIONS THROUGH ASHFIELD’S AWARD-WINNING PATIENT EXPERIENCE PLATFORM

Text/SMS communications

Connected devices / wearables

Video conferencing

Email/Mail

E-signature/survey

Printed materials and welcome kits

Social media and third party communities

HUB and specialty pharma

support

Mobile

Hospital to home support

In-home education

Phone and live chat

MEDICAL AFFAIRSWe are a nimble and flexible organization, offering dedicated, shared and hybrid staffing models. This allows emerging biopharma companies to manage operational costs and flex quickly in response to volume trends.

Our approach combines:

• Adverse event intake / reporting • Product complaint handling • Medical and technical information request handling

(Tier 1 and 2) • Medical writing• Crisis management • Compassionate use support• Conference support• Clinical trial support• REMS and patient registration support

Our Medical Information services

375+Medical

Informationstaff

Multichannel solutions to drive

customer experience and engagement

>97%Overall

quality score

UNSURPASSED EXPERTISELong-standing programs upheld by industry experts and cutting-edge technologies.

LEADING QUALITY STANDARDSRaising the bar for quality benchmarks, recruiting talented professionals and training for excellence.

GLOBAL AGILITYEfficient, global operations delivered through proactive, highly flexible partnerships.

To find out more about how Ashfield develops tailored, flexible solutions for emerging biopharma companies, please contact: solutions@ashfieldhealthcare.com

MSLs, VIRTUAL MSLs AND MSL MANAGEMENT

Virtual MSL• Operate >80% remotely• Increase reach and frequency of

scientific exchange• Increase MSL team efficiency and

national coverage• Cost efficiency versus field MSLs

Current MSLs hold a doctorate degree (MD, PharmD, PhD)

>90%

REAL-TIME RECRUITMENT: Our executive search recruiters follow proven process and an agreed upon profile to build an essential candidate pool.

STRATEGIC INSIGHTS: We use our performance management process to ensure MSLs gather insights that drive medical strategy and high-quality education.

TECHNOLOGY: Our MSL model is underpinned by a full feature, compliant CRM and reporting platform.